Part-time private investor. I aggregate info and have a positive skew to support my investments. Not financial advice.
England, United Kingdom
Joined June 2022
- Tweets7K
- Following262
- Followers1.7K
- Likes23.5K
Pinned Tweet
#AXV AXIES VENTURES
TG 🔗 👇🏻
Copper & Gold AIM IPO set for mid-October with EIS 📃
Location - Cyprus & Canada
BoD - former Anglo-American project managers
Resource - 72m 0.5-0.8 Cu open across & at depth
News - 💎 drill campaign to follow IPO ->MRE
t.me/+wKRaxZqvj641ZDhk
DeadEyeBeaky retweeted
Hats off to Ian and the team.
We are fully focused on commercial opportunities, we don't accept loss making contracts (other might) we work hard, we don't take large salaries (yet) and we have proven as a team we can achieve more than those who doubt us... #PYC
#PYC We have secured additional contract wins amounting to £970,000 since May 2026.
Furthmore.Mr Bagnall reaffirms the strategic commercial focus maintained by our current board.
We are pleased to be upgrading our IT infrastructure and internal compliance frameworks.
DeadEyeBeaky retweeted
#PYC contracts amounting to £970k since early 2026. This is great news. However, that figure could be morphed when #Docetaxel is validated & being used in various territories around the globe. A personal Docetaxel dose could save lots of £ & help stop adverse drug reactions.
DeadEyeBeaky retweeted
#PYC We have secured additional contract wins amounting to £970,000 since May 2026.
Furthmore.Mr Bagnall reaffirms the strategic commercial focus maintained by our current board.
We are pleased to be upgrading our IT infrastructure and internal compliance frameworks.
🤖 Made with AI
DeadEyeBeaky retweeted
And here comes #axv ………
Copper needs $ 332bn of new mines.
Each one takes about 17 years to build.
Bloomberg new outlook sees a deficit starting in 2028 and widening to 20 million tonnes by 2050.
That’s about 44% of demand.
9 of the 10 transition metals it tracks now look covered. Copper is the odd one out.
Demand rises 61% to almost 46 million tonnes by 2050. Electric transport alone needs 11.4 million.
You can print money.... You can’t print a mine.
DeadEyeBeaky retweeted
Having committed a fair amount of capital to this turnaround project, I’m delighted with the very evident progress.
It will be reflected in the share price sooner rather than later as investors wake up.
#PYC
DeadEyeBeaky retweeted
#PYC HUGE POTENTIAL HERE 🔥
CONTRACT WINS ACCELERATING, GROWING PHARMA PIPELINE, LOWER COSTS, US EXPANSION, NHS DOSING TECHNOLOGY, WELLNESS MARKETS & GLOBAL LICENSING OPPORTUNITIES!
SCALABLE SOFTWARE, RECURRING REVENUE POTENTIAL & VALUABLE IP!
SELF EXPLANATORY 🔥📈💪
DeadEyeBeaky retweeted
#PYC PHYSIOMICS IS BUILDING SERIOUS MOMENTUM! 📈
ANOTHER £102K CONTRACT TODAY!
OVER £970K IN CONTRACT WINS SINCE MAY, ALREADY EXCEEDING FY26 REVENUE OF £941K!
FY27 ONLY STARTED 1 JULY!
RECORD PIPELINE, REDUCED COSTS, GROWING REVENUE 👀
THE UPSIDE COULD BE HUGE 🔥💪🔥
DeadEyeBeaky retweeted
#PYC @Physiomics
Physiomics has now secured over £970,000 in contract awards since May 2026, already exceeding its entire FY2026 revenue of £941,222.
The latest £102,000 contract is another addition to that growing momentum.
And this is where the bigger picture matters. 👇
DeadEyeBeaky retweeted
Contract Win #PYC RNS
This contract brings the total value of contract awards announced since May 2026 to more than £970,000 , which compares with revenue of £941,222 reported in our recently released Annual Report for the year ended 30 June 2026
londonstockexchange.com/news…
DeadEyeBeaky retweeted
The profit vs loss dynamic of junior mining and exploration from the last 35 years. The cycle is with us, so where do we go this time? And which are your chosen junior explorers to ride the cycle? #metals #mining #commodities
DeadEyeBeaky retweeted
Contracts News & Non-Binding Agreement, in addition to our annual report.
Physiomics racks up £750k in contracts since May #PYC
share.google/bPm5vk3lD5i1idh…
DeadEyeBeaky retweeted
@Physiomics (AIM #PYC) has secured a new £119,000 contract for drug development modelling while exploring additional commercial opportunities for its personalised dosing technology, including potential expansion into the US and wellness markets.
@DDS_DocHoliday Executive Director of Physiomics, said: “This contract is a strong example of our team’s ability to move quickly and deliver and we are delighted that it was swiftly and efficiently executed. We are equally focused on exploring the wider commercial potential of our personalised dosing technology, and on finding the right opportunities to build value from our relationships and intellectual property.” share-talk.com/physiomics-se…
@Physiomics (AIM #PYC) reported its highest annual income since incorporation, with revenue and grant income rising 26.5% to £1.06 million in the year ended 30 June 2026. Physiomics also ended the year with what it described as a record contract pipeline.
The mathematical modelling, data science and biostatistics company said the result met board expectations and was supported by 24 new contract awards across oncology, immunology, infectious disease and renal disease. @NickTulloch2 @IanBagnall1 @DDS_DocHoliday
share-talk.com/physiomics-re…
DeadEyeBeaky retweeted
Physiomics posts record income, expands biometrics amid higher one-off costs - TipRanks.com share.google/oAwgKs31SmNoMcI…
DeadEyeBeaky retweeted
#PYC
HUGE POTENTIAL!
£119K contract secured and talks to commercialise personalised dosing IP in the US and wider wellness sector.
Access to a multibillion market could unlock licensing, recurring revenues and significant scalability.
Early stage, but enormous upside! 🔥
DeadEyeBeaky retweeted
#PYC The market will catch on to the shift from the old management to the new soon; yesterday's annual report closes that chapter, and since we joined Physiomics, we've brought in almost £870k in contracts since May!
We work, close deals, and keep growing together.🙏
Contract Win and Exploration of Additional Commercial Opportunities
The speed in which this agreement was finalised and concluded is testament to the teams efficency.
We keep growing and we keep improving, together 👏
londonstockexchange.com/news…
DeadEyeBeaky retweeted
Contract Win and Exploration of Additional Commercial Opportunities
The speed in which this agreement was finalised and concluded is testament to the teams efficency.
We keep growing and we keep improving, together 👏
londonstockexchange.com/news…
DeadEyeBeaky retweeted
We are really proud of the team and the progress we are making, not helped by the outgoing board.
A special thanks to @IanBagnall1 for his efforts to reduce the unnecessary spend within the business.
We have an exciting period ahead of us, complimented with a robust strategy.
DeadEyeBeaky retweeted
@Physiomics (AIM #PYC) reported its highest annual income since incorporation, with revenue and grant income rising 26.5% to £1.06 million in the year ended 30 June 2026. Physiomics also ended the year with what it described as a record contract pipeline.
The mathematical modelling, data science and biostatistics company said the result met board expectations and was supported by 24 new contract awards across oncology, immunology, infectious disease and renal disease. @NickTulloch2 @IanBagnall1 @DDS_DocHoliday
share-talk.com/physiomics-re…